{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:40:56Z","timestamp":1791308456017,"version":"4.3.1"},"reference-count":24,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T00:00:00Z","timestamp":1541116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Instituto Nacional de Cardiolog\u00eda Ignacio Ch\u00e1vez, Ministry of Health"}],"content-domain":{"domain":["acrjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Arthritis Care &amp; Research"],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To assess potential associations among serum cytokines and micro\n                      <jats:styled-content style=\"fixed-case\">RNA<\/jats:styled-content>\n                      (miR) levels with ultrasound (\n                      <jats:styled-content style=\"fixed-case\">US<\/jats:styled-content>\n                      ) findings suggestive of urate deposits in chronic asymptomatic hyperuricemia and gout.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      All participants underwent musculoskeletal\n                      <jats:styled-content style=\"fixed-case\">US<\/jats:styled-content>\n                      and measurements of serum interleukin\u20101\u03b2 (\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u20101\u03b2),\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u20102,\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u20104,\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u20105,\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u20106,\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u20108,\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u201010,\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u201012,\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u201013, interferon\u2010\u03b3, tumor necrosis factor, monocyte chemoattractant protein 1, and epithelial neutrophil\u2013activating peptide 78, as well as miR\u2010146a, miR\u2010155, and miR\u2010223 levels.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thirty individuals with asymptomatic hyperuricemia, 31 normouricemic controls, and 30 patients with gout were included. The frequency of synovitis and double contour sign using\n                      <jats:styled-content style=\"fixed-case\">US<\/jats:styled-content>\n                      was similar between asymptomatic hyperuricemia (67% and 27%, respectively) and patients with gout (77% and 27%, respectively), and each had a higher frequency than controls (45% and 0%, respectively). Serum\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u20106 and\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u20108 levels were similar between patients with asymptomatic hyperuricemia (mean \u00b1\n                      <jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>\n                      69.7 \u00b1 73.4 and 18.5 \u00b1 25.6 pg\/ml, respectively) and gout (mean \u00b1\n                      <jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>\n                      75.8 \u00b1 47.6 and 24.4 \u00b1 31.7 pg\/ml, respectively), and higher than controls (mean \u00b1\n                      <jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>\n                      28.2 \u00b1 17.6 and 7.4 \u00b1 6.0 pg\/ml, respectively). A similar distribution was observed for miR\u2010155 levels in asymptomatic hyperuricemia, patients with gout, and controls (mean \u00b1\n                      <jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>\n                      0.22 \u00b1 0.18, 0.20 \u00b1 0.14, and 0.08 \u00b1 0.04, respectively). Associations between morphostructural abnormalities suggestive of urate deposits (regardless of clinical diagnosis) and serum markers were assessed. Subjects with urate deposits had higher\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u20106 (257.2 versus 47.0 pg\/ml;\n                      <jats:italic>P<\/jats:italic>\n                      = 0.005),\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u20108 (73.2 versus 12.0 pg\/ml;\n                      <jats:italic>P<\/jats:italic>\n                      = 0.026), and miR\u2010155 (0.21 versus 0.16;\n                      <jats:italic>P<\/jats:italic>\n                      = 0.015) levels than those without deposition findings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      In individuals with chronic asymptomatic hyperuricemia, the presence of synovitis and double contour sign by\n                      <jats:styled-content style=\"fixed-case\">US<\/jats:styled-content>\n                      may represent a subclinical manifestation of monosodium urate crystal nucleation, capable of triggering inflammatory pathways (\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u20106 and\n                      <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\n                      \u20108) and mechanisms of intercellular communication (miR\u2010155), similar to what is observed in patients with gout.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/acr.23549","type":"journal-article","created":{"date-parts":[[2018,2,18]],"date-time":"2018-02-18T20:32:44Z","timestamp":1518985964000},"page":"1814-1821","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Levels of Cytokines and Micro\n                    <scp>RNA<\/scp>\n                    s in Individuals With Asymptomatic Hyperuricemia and Ultrasonographic Findings of Gout: A Bench\u2010to\u2010Bedside Approach"],"prefix":"10.1002","volume":"70","author":[{"given":"Irving O.","family":"Estevez\u2010Garcia","sequence":"first","affiliation":[{"name":"Instituto Nacional de Cardiolog\u00eda Ignacio Ch\u00e1vez Mexico City Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Gallegos\u2010Nava","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Rehabilitaci\u00f3n Luis Guillermo Ibarra Ibarra Hospital General Dr. Dar\u00edo Fern\u00e1ndez Fierro, and Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado Mexico City Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Vera\u2010P\u00e9rez","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Rehabilitaci\u00f3n Luis Guillermo Ibarra Ibarra Mexico City Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis H.","family":"Silveira","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Cardiolog\u00eda Ignacio Ch\u00e1vez Mexico City Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Ventura\u2010R\u00edos","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Rehabilitaci\u00f3n Luis Guillermo Ibarra Ibarra Mexico City Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Vancini","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Cardiolog\u00eda Ignacio Ch\u00e1vez Mexico City Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Hern\u00e1ndez\u2010D\u00edaz","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Rehabilitaci\u00f3n Luis Guillermo Ibarra Ibarra Mexico City Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"S\u00e1nchez\u2010Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Cardiolog\u00eda Ignacio Ch\u00e1vez Mexico City Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha A.","family":"Ballinas\u2010Verdugo","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Cardiolog\u00eda Ignacio Ch\u00e1vez Mexico City Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwin","family":"Gutierrez","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Rehabilitaci\u00f3n Luis Guillermo Ibarra Ibarra Mexico City Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Pineda","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Rehabilitaci\u00f3n Luis Guillermo Ibarra Ibarra Mexico City Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Rodriguez\u2010Henriquez","sequence":"additional","affiliation":[{"name":"Hospital General Dr. Manuel Gea Gonz\u00e1lez Mexico City Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Castillo\u2010Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Hospital General de Zona 32 and Instituto Mexicano del Seguro Social Coyoac\u00e1n, Mexico City Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6258-5732","authenticated-orcid":false,"given":"Luis M.","family":"Amezcua\u2010Guerra","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Cardiolog\u00eda Ignacio Ch\u00e1vez Universidad Aut\u00f3noma Metropolitana\u2212Xochimilco, and Unidad de Investigaci\u00f3n Traslacional UNAM\/INC Mexico City Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,11,2]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.703389"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160452"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S115080"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3223"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev112"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/15257770802136040"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e31827d8790"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4531"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205409"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201516"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39254"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.425"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.7.641"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.10.064"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2010.194"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/15257770.2015.1124999"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket474"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.01.018"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23386"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1019536108"},{"key":"e_1_2_6_22_1","first-page":"126","article-title":"Aberrant hypermethylation of the suppressor of cytokine signaling 1 gene and its potential role in gouty patients","volume":"2","author":"Chung YH","year":"2015","journal-title":"Gout Hyperuricemia"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature01991"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-011-0162-1"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2011.01040.x"}],"container-title":["Arthritis Care &amp; Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Facr.23549","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acr.23549","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/acr.23549","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acr.23549","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T17:02:31Z","timestamp":1759424551000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/acr.23549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,2]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.1002\/acr.23549"],"URL":"https:\/\/doi.org\/10.1002\/acr.23549","archive":["Portico"],"relation":{},"ISSN":["2151-464X","2151-4658"],"issn-type":[{"value":"2151-464X","type":"print"},{"value":"2151-4658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,2]]},"assertion":[{"value":"2017-08-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}